Master in Medical and Pharmaceutical Biotechnologies

Tuition comes to 2,885 USD per year.

Medical and pharmaceutical biotechnology focuses on the science behind the discovery, development, and production of drugs and other therapeutic products, combining biology, chemistry, and pharmacology. Students in this field typically study molecular biology, pharmacology, biochemistry, and drug development processes, along with more technical subjects such as recombinant technology and the production of biological and pharmaceutical products. The discipline connects laboratory science with the practical steps involved in moving a potential treatment from early research through testing and toward eventual clinical use. This Medical and Pharmaceutical Biotechnologies program is offered at the master's level by Universita degli Studi di Pavia, located in Pavia, Italy, and is taught in English. Following the two-year structure standard for master's degrees in the European system, the program combines advanced coursework with laboratory training and typically a research-based thesis in an area of medical or pharmaceutical biotechnology. Graduates typically pursue careers in pharmaceutical and biotechnology companies, working in areas such as drug discovery, development, and quality control, as well as in regulatory bodies responsible for approving new medical products. Others move into clinical and research laboratories, or contract research organizations that support pharmaceutical development on behalf of other companies. Some continue into doctoral research, working toward academic or advanced industry research careers. Because the pharmaceutical and biotechnology sectors involve close collaboration between scientists, regulators, and clinicians, graduates with training in medical and pharmaceutical biotechnology are often positioned to work across different stages of the drug development process, from initial laboratory research through to the later stages of testing and production.